Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibiotics.

BMY 28142, a new broad-spectrum semisynthetic cephalosporin, was evaluated in vitro and in vivo in comparison with ceftazidime, cefotaxime, moxalactam, and cefoperazone. The activity of BMY 28142 compared favorably with the activities of the other compounds against both Pseudomonas aeruginosa and St...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Kessler, R E, Bies, M, Buck, R E, Chisholm, D R, Pursiano, T A, Tsai, Y H, Misiek, M, Price, K E, Leitner, F
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1985
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC176239/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3885849/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.27.2.207
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!